Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07182357 · ClinicalTrials.gov registry record · NA
Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia
A NA study, sponsored by New York University.
- Recruiting
- Registry status
- NA
- Development phase
- 96
- Enrollment target
NCT07182357: Recruiting NA study, sponsored by New York University.
NCT07182357 is a NA study that is actively recruiting participants, run by New York University. The registered enrollment target is 96 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07182357, a NA study, is actively recruiting participants, sponsored by New York University.
- RECRUITING
- Registry status
- NA
- Development phase
- 96 participants
- Enrollment target
Study Summary
This study will test a care management intervention to guide end-of-life care and hospice transitions for persons with dementia and their care partners receiving home healthcare and ascertain feasibility, acceptability, fidelity, and usability of a dementia care management hospice transitions checklist. This study will also examine hospice enrollment, time to enrollment, and care partner satisfaction with the intervention. The intervention will be delivered within usual care management within a large home healthcare agency.
Primary Outcome
The primary outcome is feasibility. Feasibility will be measured for each group including recruitment and retention rates, rate of completion of the intervention as the proportion of individuals who use and receive the intervention, and whether the different components of the intervention are achievable.
Interventions
- BEHAVIORAL Dementia Care Management Checklist for Hospice Transitions
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2026-05-13 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT07182357 shows while recruiting
NCT07182357 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 96 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Dementia Care Management Checklist for Hospice Transitions is the first listed.
NCT07182357 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07182357 about?
NCT07182357 is a clinical study titled "Designing Care Management for Hospice Transitions for Persons Living With Advanced Dementia". This study will test a care management intervention to guide end-of-life care and hospice transitions for persons with dementia and their care partners receiving home healthcare and ascertain feasibility, acceptability, fidelity, and usability of a dementia care management hospice transitions checkl...
What is the current status of trial NCT07182357?
This trial is currently recruiting. It is a NA study. The enrollment target is 96 participants. The study started on 2026-05-13. Estimated completion is 2028-07-31.
What interventions are being tested in trial NCT07182357?
The interventions under investigation include: Dementia Care Management Checklist for Hospice Transitions (BEHAVIORAL).
Who is sponsoring clinical trial NCT07182357?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07182357's enrollment target sits among peer trials
96 925th of 2000 higher than 1,070 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI